Diabetes Mellitus, Type 2 Clinical Trial
— HOtBEDOfficial title:
The Effects of HOme-Based Combined Exercise on Glycaemic Control and Anthropometric Measurements in Patients With Type 2 Diabetes
| NCT number | NCT03103126 |
| Other study ID # | HOtBED |
| Secondary ID | |
| Status | Withdrawn |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 1, 2019 |
| Est. completion date | September 1, 2019 |
| Verified date | March 2020 |
| Source | University of Portsmouth |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The study aims to investigate whether 12 weeks of structured aerobic and resistance exercises
completed at home can have a beneficial effect on the health of patients with type 2 diabetes
compared to standard physical activity advice. The study will investigate whether the
exercises can reduce factors such as patient's BMI, blood pressure and waist circumference,
as well as blood glucose and insulin sensitivity. Participants will use pedometers and
Therabands to carry out their exercises.
This will be compared to giving participants a physical activity advice sheet and no
structured exercise examples.
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | September 1, 2019 |
| Est. primary completion date | July 1, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Participants must not be meeting the government's recommended physical activity guideline (150 min moderate intensity exercise per week) - Must be 18 years of age or over - Diagnosed with Type 2 Diabetes and have been referred to DESMOND, as this is where they will be recruited from. Exclusion Criteria: ? Co-morbidity that prevents them undertaking physical activity safely, such as cardiac disease or pulmonary disease or significant musculoskeletal limitations. This will be determined from the Exercise and Health History Questionnaire. If their diabetes is severe and they have peripheral neuropathy or any associated systemic, cardiovascular, metabolic or musculoskeletal problems which will inhibit their ability to perform exercise safely. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Andrew Scott | Portsmouth | Hampshire |
| Lead Sponsor | Collaborator |
|---|---|
| University of Portsmouth | Portsmouth Hospitals NHS Trust |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The effects of home-based combined exercise on insulin sensitivity compared to physical activity advice during the 6 week study period | Insulin sensitivity will be calculated from plasma glucose and serum insulin measures | 6 weeks | |
| Secondary | The effects of HBCE on body mass index (BMI) compared to physical activity advice during the 6 week study period | Height and body mass will be measured to determine whether the intervention improves BMI (kg.m2) | 6 weeks | |
| Secondary | The effects of HBCE on waist circumference compared to physical activity advice during the 6 week study period | To determine whether the intervention improves waist circumference in centimetres | 6 weeks | |
| Secondary | The effects of HBCE on body fat percentage compared to physical activity advice during the 6 week study period | To determine whether the intervention improves body fat percentage using bioelectrical impedance analysis | 6 weeks | |
| Secondary | The effect of HBCE on physical activity levels compared to physical activity advice during the 6 week study period | To determine if HBCE is more effective at increasing physical activity compared to physical activity advice using an International Physical Activity Questionnaire at baseline and the last week of the study period. | 6 weeks | |
| Secondary | The effect of HBCE on fitness compared to physical activity advice during the 6 week study period | To determine if HBCE is more effective at increasing fitness levels compared to physical activity advice using the Tecumseh step test, a modified version of the Harvard step test (Shorter test period and shorter step). | 6 weeks | |
| Secondary | The number of participants recruited and the average number per week | Can sufficient participant numbers can be recruited from a DESMOND day? The number of participants recruited and average per week of recruitment will be recorded and calculated. | 6 weeks | |
| Secondary | The percentage adherence to the home-based combined exercise programme | Adherence to the home-based combined exercise programme will be monitored in a diary | 6 weeks | |
| Secondary | Self-perceived health status measured using the SF-36 quality of life scale | The SF36 will be applied at baseline and post-intervention in both groups to determine any changes and differences between control vs exercise groups | 6 weeks | |
| Secondary | Self-efficacy to regulate exercise scale | The self-efficacy to regulate exercise scale will be applied at baseline and post-intervention in both groups to determine any changes and differences between control vs exercise groups | 6 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |